CompanyPALINasdaqCarlsbad, CA

Palisade Bio

Palisade Bio develops prodrugs for inflammatory and fibrotic diseases.

SEC EDGAR ClinicalTrials.gov palisadebio.com

8-KSep 29Latest SEC filing

Sep 29Latest story

September 2026

Palisade Bio registers Phase 2 trial of PALI-2108 in ulcerative colitis, recruiting begins

Sep 29Trial updatePalisade Bio

August 2026

Palisade Bio advances PALI-2108 toward Phase 2 trials in ulcerative colitis, Crohn's disease

Aug 10Quarterly updatePalisade Bio